Found: 45
Select item for more details and to access through your institution.
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
- By:
- Publication type:
- Article
Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer.
- Published in:
- Cancer Science, 1997, v. 88, n. 12, p. 1181, doi. 10.1111/j.1349-7006.1997.tb00347.x
- By:
- Publication type:
- Article
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1479, doi. 10.3892/ijo.2020.5019
- By:
- Publication type:
- Article
PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65969-3
- By:
- Publication type:
- Article
Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma.
- Published in:
- Current Oncology, 2024, v. 31, n. 4, p. 1701, doi. 10.3390/curroncol31040129
- By:
- Publication type:
- Article
Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 4, p. N.PAG, doi. 10.3892/ol.2022.13246
- By:
- Publication type:
- Article
High postoperative neutrophil-to-lymphocyte ratio as a poor prognostic marker in patients with upper tract urothelial carcinoma.
- Published in:
- Oncology Letters, 2019, v. 17, n. 6, p. 5241
- By:
- Publication type:
- Article
Holmium Laser Resection of the Prostate.
- Published in:
- Journal of Endourology, 1998, v. 12, n. 3, p. 279, doi. 10.1089/end.1998.12.279
- By:
- Publication type:
- Article
Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0075463
- By:
- Publication type:
- Article
A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomy.
- Published in:
- BJU International, 2008, v. 102, n. 8, p. 958, doi. 10.1111/j.1464-410X.2008.07759.x
- By:
- Publication type:
- Article
Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg.
- Published in:
- LUTS, 2023, v. 15, n. 3, p. 89, doi. 10.1111/luts.12474
- By:
- Publication type:
- Article
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3208, doi. 10.1002/cncr.26636
- By:
- Publication type:
- Article
Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2325, doi. 10.1002/cam4.5057
- By:
- Publication type:
- Article
Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
- Published in:
- International Journal of Urology, 2007, v. 14, n. 8, p. 713, doi. 10.1111/j.1442-2042.2007.01809.x
- By:
- Publication type:
- Article
Early catheter removal 3 days after radical retropubic prostatectomy.
- Published in:
- International Journal of Urology, 2004, v. 11, n. 11, p. 983, doi. 10.1111/j.1442-2042.2004.00935.x
- By:
- Publication type:
- Article
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 461, doi. 10.1007/s00262-021-03000-8
- By:
- Publication type:
- Article
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 847, doi. 10.1007/s00262-020-02498-8
- By:
- Publication type:
- Article
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1
- By:
- Publication type:
- Article
Paraganglioma of the urinary bladder: Case report and literature review.
- Published in:
- IJU Case Reports, 2020, v. 3, n. 5, p. 192, doi. 10.1002/iju5.12185
- By:
- Publication type:
- Article
Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine.
- Published in:
- IJU Case Reports, 2020, v. 3, n. 2, p. 44, doi. 10.1002/iju5.12139
- By:
- Publication type:
- Article
Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 479, doi. 10.1093/jjco/hyac009
- By:
- Publication type:
- Article
Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 2, p. 179, doi. 10.1093/jjco/hyab157
- By:
- Publication type:
- Article
Investigation of Effect Predictors of Desmopressin in Nocturia Patients With Nocturnal Polyuria.
- Published in:
- In Vivo, 2023, v. 37, n. 6, p. 2726, doi. 10.21873/invivo.13383
- By:
- Publication type:
- Article
Sarcopenia and the Therapeutic Effects of Androgen Receptor-axis-targeted Therapies in Patients With Castration-resistant Prostate Cancer.
- Published in:
- In Vivo, 2023, v. 37, n. 3, p. 1266, doi. 10.21873/invivo.13204
- By:
- Publication type:
- Article
Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2417, doi. 10.3390/jcm12062417
- By:
- Publication type:
- Article
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
- Published in:
- Prostate, 2012, v. 72, n. 8, p. 834, doi. 10.1002/pros.21485
- By:
- Publication type:
- Article
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.
- Published in:
- Prostate, 2004, v. 60, n. 1, p. 32, doi. 10.1002/pros.20011
- By:
- Publication type:
- Article
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.
- Published in:
- Prostate, 2003, v. 57, n. 1, p. 80, doi. 10.1002/pros.10276
- By:
- Publication type:
- Article
Immune responses of patients without cancer recurrence after a cancer vaccine over a long term.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 6, p. N.PAG, doi. 10.3892/mco.2022.2545
- By:
- Publication type:
- Article
Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2515
- By:
- Publication type:
- Article
Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 2, p. 205, doi. 10.3892/mco.2017.1294
- By:
- Publication type:
- Article
Spontaneous regression of multiple pulmonary nodules in a patient with unclassified renal cell carcinoma following laparoscopic partial nephrectomy: A case report.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 5, n. 1, p. 49, doi. 10.3892/mco.2016.900
- By:
- Publication type:
- Article
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 4, p. 362, doi. 10.1111/iju.15371
- By:
- Publication type:
- Article
Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I‐125 low‐dose‐rate brachytherapy for localized prostate cancer.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 4, p. 347, doi. 10.1111/iju.15120
- By:
- Publication type:
- Article
Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer.
- Published in:
- International Journal of Urology, 2014, v. 21, n. 7, p. 658, doi. 10.1111/iju.12411
- By:
- Publication type:
- Article
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
- Published in:
- Cancer Science, 2018, v. 109, n. 9, p. 2660, doi. 10.1111/cas.13709
- By:
- Publication type:
- Article
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 12, p. 2430, doi. 10.1111/cas.13404
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> allele.
- Published in:
- Cancer Science, 2017, v. 108, n. 4, p. 598, doi. 10.1111/cas.13189
- By:
- Publication type:
- Article
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1257, doi. 10.1111/cas.12757
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 638, doi. 10.1111/j.1349-7006.2012.02202.x
- By:
- Publication type:
- Article
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.
- Published in:
- Cancer Science, 2010, v. 101, n. 10, p. 2110, doi. 10.1111/j.1349-7006.2010.01653.x
- By:
- Publication type:
- Article
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients.
- Published in:
- Cancer Science, 2007, v. 98, n. 12, p. 1965, doi. 10.1111/j.1349-7006.2007.00631.x
- By:
- Publication type:
- Article
Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer.
- Published in:
- Cancer Science, 2004, v. 95, n. 1, p. 77, doi. 10.1111/j.1349-7006.2004.tb03174.x
- By:
- Publication type:
- Article